The role of the low resistance period in determining the effective dosage of chlortetracycline in mice. Immunological investigations in experimental chemotherapy. IV.
D000818:Animals; D002751:Chlortetracycline / Q000008:administration & dosage*; D004926:Escherichia coli / Q000187:drug effects; D004927:Escherichia coli Infections / Q000276:immunology; D066298:In Vitro Techniques; D007239:Infections / Q000276:immunology*; D007709:Klebsiella / Q000187:drug effects; D007710:Klebsiella Infections / Q000276:immunology; D008089:Listeria monocytogenes / Q000187:drug effects; D008088:Listeriosis / Q000276:immunology; D051379:Mice; D008826:Microbial Sensitivity Tests; D011008:Pneumococcal Infections / Q000276:immunology; D012481:Salmonella Infections, Animal / Q000276:immunology; D012486:Salmonella typhimurium / Q000187:drug effects; D013203:Staphylococcal Infections / Q000276:immunology; D013210:Staphylococcus / Q000187:drug effects; D013296:Streptococcus pneumoniae / Q000187:drug effects; D013997:Time Factors
D002751:Chlortetracycline